The nation of Zimbabwe has declined a major US health deal valued at $367m (272 million pounds) over five years because of Washington's request for sensitive biological samples.
The decision came to light after a internal memorandum dated December was disclosed, which showed President Emmerson Mnangagwa deemed the agreement was "lopsided".
A government spokesperson later explained that the US was demanding access to biological samples for research and profit while was unwilling to share the benefits from any future treatments.
"We must now begin the challenging and unfortunate process of scaling back our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had provided over $1.9bn in health funding to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for more talks to find a deal suitable to both sides so the country's vital HIV treatment initiative can be sustained.
Wider Implications
Zimbabwe's decision follows a comparable case in neighbouring Kenya, where a high court blocked a similar health funding agreement after concerns were filed about the security of citizens' health data.
After returning to the presidency last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
USAID had overseen assistance for the American government, but Trump argued its spending was "wasteful" and his government was pursuing direct bilateral deals to enhance transparency and accountability.
According to statements, Sixteen nations in Africa have so far signed these new health pacts, constituting more than $18.3bn in new funding.
Specifics of the Rejected Agreement
The funds for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this cooperation would have delivered extraordinary advantages for Zimbabwean communities, especially the 1.2 million currently on antiretroviral therapy via US-supported initiatives," the Ambassador added.
However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".
"The proposal required Zimbabwe to surrender its genetic material and health information indefinitely, with no corresponding assurance of benefiting from any scientific breakthroughs – such as new medicines or tests – that could be developed from that provided information," Mangwana explained.
"Effectively, our country would supply the basic resources for scientific discovery with no certainty that the resulting innovations would be accessible to our citizens if a new disease outbreak arise."
Sovereignty and Global Health
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were undermining structures previously established via the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with potential pandemics.
"This mechanism is intended to ensure that when a nation provides its information, the benefits – including vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to create them."
The government's concerns regarding the US deal "are not meant as hostility towards the US," he added.
"We are open to continued discussions with our US partners on how future collaboration might be designed in a manner that respects the independence and dignity of both nations."
Health Experts Response
A leading public health body expressed it recognised the official position, but recommended that negotiations should continue given that a large portion of the nation's Aids initiatives were funded by foreign aid.
"Where technical issues arise, such as those relating to data governance or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," it said.
The situation emphasises the continuing challenges between receiving crucial international aid and safeguarding a country's data in an increasingly interconnected world.